These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 400749)

  • 41. Effects of acute haemodialysis-induced changes in sodium balance upon experimentally hypertensive rats.
    Röckel A; Brand A; Bechinger W; Heidland A
    Contrib Nephrol; 1980; 19():139-47. PubMed ID: 6991209
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
    Marks LS; Maxwell MH; Kaufman JJ
    Lancet; 1975 Oct; 2(7939):784-7. PubMed ID: 78152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The significance of renin and angiotensin in renovascular hypertension in man.
    Fagard R; Amery A; Billiet L; Joossens JV; Lijnen P; Reybrouck T
    Acta Clin Belg; 1979; 34(3):130-9. PubMed ID: 506622
    [No Abstract]   [Full Text] [Related]  

  • 44. Saralasin test as a diagnostic and prognostic aid in renovascular hypertensive patients subjected to renal operation.
    Poutasse EF; Gonzalez-Serva L; Wendelken JR; Franz JP
    Trans Am Assoc Genitourin Surg; 1979; 71():96-100. PubMed ID: 545821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Saralasin for renovascular or essential hypertension (author's transl)].
    Arlart I; Rosenthal J
    Dtsch Med Wochenschr; 1978 Nov; 103(45):1790-6. PubMed ID: 710289
    [No Abstract]   [Full Text] [Related]  

  • 46. Saralasin for diagnosis of renovascular hypertension.
    Med Lett Drugs Ther; 1982 Jan; 24(600):3-4. PubMed ID: 7054649
    [No Abstract]   [Full Text] [Related]  

  • 47. Haemodynamic effects of Sar1-Ala8-angiotensin II in patients with renovascular hypertension.
    Fagard R; Amery A; Ljnen P; Reybrouck T; Billiet L
    Prog Biochem Pharmacol; 1976; 12():242-9. PubMed ID: 1019167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Blood pressure behavior following 1-sar-8-ala-angiotensin II (saralasin) in essential and renovascular hypertension].
    Rosenthal J; Franz HE
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1305-7. PubMed ID: 1029984
    [No Abstract]   [Full Text] [Related]  

  • 49. [The saralasin test in the diagnosis of hypertension (author's transl)].
    Bönner G; Helber A; Meurer KA; Hummerich W; Wambach G; Kaufmann W
    Dtsch Med Wochenschr; 1979 Mar; 104(12):432-7. PubMed ID: 436589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparison of effects of two angiotensin II antagonists on blood pressure, heart rate, plasma renin activity, and plasma aldosterone concentration in the same hypertensive patients].
    Higuma K; Fujishima S; Shionoiri H; Tochikubo O; Uneda S; Fujiki Y; Kaneko Y
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):425-35. PubMed ID: 6381833
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical usefulness of saralasin in human hypertension (author's transl)].
    Fouchard M; Bichara M; Grüfeld JP; Barbanel C; Meyer P; Funck-Brentano JL
    Nouv Presse Med; 1978 Feb; 7(7):539-43. PubMed ID: 643579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of saralasin as a diagnostic test in hypertension. Report of a Consensus Committee.
    Arch Intern Med; 1982 Aug; 142(8):1437-40. PubMed ID: 7049102
    [No Abstract]   [Full Text] [Related]  

  • 53. Response to saralasin and angiotensin's role in essential and renal hypertension.
    Hollenberg NK; Williams GH; Adams DF; Moore T; Brown C; Borucki LJ; Leung F; Bavli S; Solomon HS; Passan D; Dluhy R
    Medicine (Baltimore); 1979 Mar; 58(2):115-27. PubMed ID: 431398
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical experience with saralasin infusion in hypertensive patients.
    Tegtmeyer CJ; Latour EA; Vaughan ED; Ayers CR; Carey RM; Wellons HA
    Invest Radiol; 1977; 12(6):496-504. PubMed ID: 591250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antihypertensive effects of captopril and saralasin in essential and renal hypertension.
    Konrads A; Meurer KA; Hummerich W; Wambach G; Kindler J; Feltkamp H; Helber A
    Am J Cardiol; 1982 Apr; 49(6):1558-60. PubMed ID: 7041597
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis of angiotensinogenic hypertension: the complementary roles of renal scintigraphy and the saralasin infusion test.
    McAfee JG; Thomas FD; Grossman Z; Streeten DH; Dailey E; Gagne G
    J Nucl Med; 1977 Jul; 18(7):669-75. PubMed ID: 874145
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical evaluation of renovascular hypertension and therapeutic decisions.
    Vaughan ED; Case DB; Pickering TG; Sosa RE; Sos TA; Laragh JH
    Urol Clin North Am; 1984 Aug; 11(3):393-407. PubMed ID: 6205495
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Saralasin infusion in renovascular hypertension: increased response rate in seated patients.
    Tucker RM; Sheps SG; Brennan LA
    Mayo Clin Proc; 1980 Feb; 55(2):99-102. PubMed ID: 7354651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The saralasin test in clinical evaluation of hypertensive states].
    Cremoncini C; Cremoncini M; Libroia A; Vignati E; Botalla L
    Boll Soc Ital Cardiol; 1978; 23(8):1291-7. PubMed ID: 398708
    [No Abstract]   [Full Text] [Related]  

  • 60. [Critical analysis of the saralasintest in the diagnosis of hypertension (author's transl)].
    Röckel A; Wernze H; Sabel B; Heidland A
    Klin Wochenschr; 1977 Jul; 55(13):651-6. PubMed ID: 895003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.